Fatigue News and Research

RSS

Public health agencies try to restore trust as they fight misinformation

By the summer of 2021, Phil Maytubby, deputy CEO of the health department here, was concerned to see the numbers of people getting vaccinated against covid-19 slipping after an initially robust response.

4 Jan 2023

Study finds prevalence of caffeine intake is lower during pregnancy compared to pre-pregnancy, although it increases throughout pregnancy

In the present study, caffeine consumption was assessed before and during pregnancy, as well as fluctuations in caffeine intake and variables related to non-compliance with caffeine intake recommendations during pregnancy.

4 Jan 2023

Subtle variations in every day cognitive performance associated with susceptibility to viral illness

If your alertness and reaction time is see-sawing more than usual, you may be more at risk of a viral illness.

3 Jan 2023

Analyzing electronic medical records to identify COVID-19 sequelae

In a recent study published in the journal Emerging Infectious Diseases, researchers analyzed and compared pre‒ and post‒COVID-19 diagnostic codes to identify symptoms that had higher encounter incidence in the post‒COVID-19 period as sequelae. COVID-19 sequelae and future emerging diseases can be generated and monitored using this method.

3 Jan 2023

COVID-19 vaccine safe for children who have had MIS-C

A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis or MIS-C reoccurrence.

3 Jan 2023

How can we characterize the burden of post-acute sequelae of COVID-19 in the community?

Researchers characterized the burden of post-acute sequelae of coronavirus disease 2019 (COVID-19) [PASC] in community-dwelling individuals.

3 Jan 2023

What are the long-term consequences following COVID-19 and other viral respiratory infections?

Researchers compared coronavirus disease 2019 (COVID-19)-specific long-term consequences to other viral respiratory infections.

29 Dec 2022

Study provides safety assurance to the global population regarding COVID-19 booster vaccines

In a first-of-its-kind study, researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches and monitored their physiological parameters over two years.

28 Dec 2022

An estimated 19 million US adults living with long-COVID

In a recent study published in the journal Clinical Infectious Diseases, a team of researchers examined the risk factors and prevalence and impact of long coronavirus disease (COVID) among a representative sample of adults in the United States (U.S.) and reported that close to 19 million U.S. adults suffer from long COVID.

26 Dec 2022

Study helps understand why some people have persistent smell loss after COVID-19 infection

The reason some people fail to recover their sense of smell after COVID-19 is linked to an ongoing immune assault on olfactory nerve cells and an associated decline in the number of those cells, a team of scientists led by Duke Health report.

21 Dec 2022

Sotorasib achieves meaningful anticancer activity in patients with KRAS G12C-mutated metastatic pancreatic cancer

In the Phase I/II CodeBreaK 100 trial, the KRAS G12C inhibitor sotorasib achieved meaningful anticancer activity with an acceptable safety profile in heavily pretreated patients with KRAS G12C-mutated metastatic pancreatic cancer, according to researchers at The University of Texas MD Anderson Cancer Center.

21 Dec 2022

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Researchers observe that COVID-19 patients were at an increased risk of developing certain conditions.

21 Dec 2022

Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination

Researchers report the frequencies of novel POTS-related diagnoses prior to and after SARS-CoV-2 infection and COVID-19 vaccination.

20 Dec 2022

Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?

Researchers assessed the impact of ivermectin on the duration of sustained recovery among coronavirus disease 2019 (COVID-19) outpatients.

20 Dec 2022

Active transmission of Bourbon virus in New York

A recent study published in Emerging Infectious Diseases reported on the bourbon virus (BRBV) transmission in New York.

20 Dec 2022

Persistent smell loss mostly prevalent among long Covid patients

Smell loss is one of the most prevalent symptoms of long Covid according to a new study from the University of East Anglia.

20 Dec 2022

Cancer patients with sickle cell disease report reduction in pain and anxiety in response to music therapy

A new study from University Hospitals Connor Whole Health found patients with cancer and patients with sickle cell disease (SCD) treated at an academic cancer center reported clinically significant reductions in pain and anxiety in response to music therapy.

19 Dec 2022

Fatigue News and Research

Public health agencies try to restore trust as they fight misinformation

Study finds prevalence of caffeine intake is lower during pregnancy compared to pre-pregnancy, although it increases throughout pregnancy

Subtle variations in every day cognitive performance associated with susceptibility to viral illness

Analyzing electronic medical records to identify COVID-19 sequelae

COVID-19 vaccine safe for children who have had MIS-C

How can we characterize the burden of post-acute sequelae of COVID-19 in the community?

What are the long-term consequences following COVID-19 and other viral respiratory infections?

Study provides safety assurance to the global population regarding COVID-19 booster vaccines

An estimated 19 million US adults living with long-COVID

Study helps understand why some people have persistent smell loss after COVID-19 infection

Sotorasib achieves meaningful anticancer activity in patients with KRAS G12C-mutated metastatic pancreatic cancer

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination

Can ivermectin improve the duration of sustained recovery among COVID-19 outpatients?

Active transmission of Bourbon virus in New York

Persistent smell loss mostly prevalent among long Covid patients

Cancer patients with sickle cell disease report reduction in pain and anxiety in response to music therapy

Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection

How Can Virtual Reality Aid Physical Therapy?

Exploring microstructural brain abnormalities after mild COVID-19

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News